BeyondSpring Reports Fourth-Quarter and Full-Year 2019 Financial Results and Operational Update

    NEXT STORY
    Calithera Biosciences Announces Telaglenastat KEAPSAKE Trial in Progress Abstract Accepted for Presentation at ASCO20 Virtual Annual Meeting
    PREV STORY
    ProMIS Neurosciences creates novel intrabodies for ALS, frontotemporal dementia and other neurodegenerative diseases
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Progenics Pharmaceuticals Provides Update on Reconstituted Board’s Ongoing Strategic Review

    author_avatar
    NASDAQ Market News

    Ziopharm Oncology Reports Second Quarter 2018 Financial Results and Provides Corporate Update

    Company Focused on Responding to FDA for Third-generation Trial NCI to file IND for ...

    author_avatar
    NASDAQ Market News

    Radius Health Provides Update on CHMP Opinion for Abaloparatide-SC

    WALTHAM, Mass., March 22, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven ...

    author_avatar
    NASDAQ Market News